Significant Accounting Policies (Narrative) (Details)	7 Months Ended
	Dec. 31, 2021 USD ($) $ / shares
Subsidiary, Sale of Stock [Line Items]
Cash equivalents	$ 0
Accretion Expense	16,715,815
Stock issuance costs	$ 16,709,861
Triggering event, stock price one | $ / shares	$ 10
Triggering event, stock price two | $ / shares	15
Triggering event, stock price three | $ / shares	$ 20
Additional Paid-in Capital [Member]
Subsidiary, Sale of Stock [Line Items]
Accretion Expense	$ 9,749,902
Accumulated Deficit [Member]
Subsidiary, Sale of Stock [Line Items]
Accretion Expense	$ 6,965,913